从福尔马林固定石蜡包埋样本中进行全基因组单细胞拷贝数分析
本文描述了一种从福尔马林固定石蜡包埋临床肿瘤样本中获取单细胞核并进行全基因组拷贝数分析的稳健且准确的方法的开发与验证,并将其应用于研究乳腺导管原位癌向浸润性癌的进展,揭示原位癌在诊断时即存在瘤内遗传异质性,且可通过多种演化过程进展为浸润性癌。
要点
- 建立了从福尔马林固定石蜡包埋肿瘤样本中进行全基因组单细胞拷贝数分析的方法。
- 该方法稳健且准确,可用于临床肿瘤样本的单细胞基因组研究。
- 乳腺导管原位癌在诊断时即存在瘤内遗传异质性,并可通过多种演化过程进展为浸润性癌。
核心结论
- 所开发的从福尔马林固定石蜡包埋临床肿瘤样本中获取单细胞核进行全基因组拷贝数分析的方法稳健且准确。
- 乳腺导管原位癌在诊断时即表现出瘤内遗传异质性,且这些病变可能通过多种演化过程进展为浸润性乳腺癌。
研究设计与样本
- 本研究为方法学开发与验证研究,并应用所建立的单细胞测序方法研究乳腺导管原位癌向浸润性癌的进展。
主要发现
- 该方法可对福尔马林固定石蜡包埋临床肿瘤样本中的单细胞核进行全基因组拷贝数分析。
- 乳腺导管原位癌在诊断时即显示瘤内遗传异质性。
- 乳腺导管原位癌可能通过多种演化过程进展为浸润性乳腺癌。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A substantial proportion of tumors consist of genotypically distinct subpopulations of cancer cells. This intratumor genetic heterogeneity poses a substantial challenge for the implementation of precision medicine. Single-cell genomics constitutes a powerful approach to resolve complex mixtures of cancer cells by tracing cell lineages and discovering cryptic genetic variations that would otherwise be obscured in tumor bulk analyses. Because of the chemical alterations that result from formalin fixation, single-cell genomic approaches have largely remained limited to fresh or rapidly frozen specimens. Here we describe the development and validation of a robust and accurate methodology to perform whole-genome copy-number profiling of single nuclei obtained from formalin-fixed paraffin-embedded clinical tumor samples. We applied the single-cell sequencing approach described here to study the progression from in situ to invasive breast cancer, which revealed that ductal carcinomas in situ show intratumor genetic heterogeneity at diagnosis and that these lesions may progress to invasive breast cancer through a variety of evolutionary processes.
引用
- Martelotto LG, Baslan T, Kendall J, et al. Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples. Nat Med. 2017. PMID: 28165479. doi:10.1038/nm.4279
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。